Additional cytogenetic features determine outcome in patients allografted for TP53 mutant acute myeloid leukemia

BACKGROUND: The presence of TP53 mutations is associated with an unfavorable outcome in patients allografted for acute myeloid leukemia (AML), leading some to question the benefit of an allogeneic stem cell transplantation (allo‐SCT) for this patient group, although this has not been studied in a la...

Descripción completa

Detalles Bibliográficos
Autores principales: Loke, Justin, Labopin, Myriam, Craddock, Charles, Cornelissen, Jan J., Labussière‐Wallet, Hélène, Wagner‐Drouet, Eva Maria, Van Gorkom, Gwendolyn, Schaap, Nicolaas P.M., Kröger, Nicolaus M., Veelken, Joan Hendrik, Rovira, Montserrat, Menard, Anne Lise, Bug, Gesine, Bazarbachi, Ali, Giebel, Sebastian, Brissot, Eolia, Nagler, Arnon, Esteve, Jordi, Mohty, Mohamad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9545190/
https://www.ncbi.nlm.nih.gov/pubmed/35612815
http://dx.doi.org/10.1002/cncr.34268

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9545190/
https://www.ncbi.nlm.nih.gov/pubmed/35612815
http://dx.doi.org/10.1002/cncr.34268

Ejemplares similares